References
- Solanki AB, Parikh JR, Parikh RH. Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken design. AAPS PharmSciTech 2007; 8:E86; http://dx.doi.org/10.1208/pt0804086; PMID: 18181547
- Dillen K, Vandervoort J, Mooter GV. Verheyden, Ludwig A. Factorial design, physicochemical characterization and activity of ciprofloxacin-PLGA nanoparticles. Int J Pharm 2004; 275:171 - 87; http://dx.doi.org/10.1016/j.ijpharm.2004.01.033; PMID: 15081148
- Avgoustakis K. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery. Curr Drug Deliv 2004; 1:321 - 33; http://dx.doi.org/10.2174/1567201043334605; PMID: 16305394
- Beletsi A, Leontiadis L, Klepetsanis P, Ithakissios DS, Avgoustakis K. Effect of preparative variables on the properties of poly(dl-lactide-co-glycolide)-methoxypoly(ethyleneglycol) copolymers related to their application in controlled drug delivery. Int J Pharm 1999; 182:187 - 97; http://dx.doi.org/10.1016/S0378-5173(99)00058-7; PMID: 10341308
- Pandey R, Khuller GK. Oral nanoparticle-based antituberculosis drug delivery to the brain in an experimental model. J Antimicrob Chemother 2006; 57:1146 - 52; http://dx.doi.org/10.1093/jac/dkl128; PMID: 16597631
- Yin YS, Chen DW, Qiao MX, Lu Z, Hu HY. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin. J Control Release 2006; 116:337 - 45; http://dx.doi.org/10.1016/j.jconrel.2006.09.015; PMID: 17097180
- Jain A, Chasoo G, Singh SK, Saxena AK, Jain SK. Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain: in vitro characterisation. J Microencapsul 2011; 28:21 - 8; http://dx.doi.org/10.3109/02652048.2010.522257; PMID: 21171813